Unyango lwaseTshayina lwe-squamous olungelulo oluncinci lomhlaza wemiphunga

Ukuqonda kunye nokuNyanga i-China Squamous Non-Small Cell Lung Cancer

Esi sikhokelo sibanzi siphonononga ubunzima be China squamous non-incinci unyango umhlaza wemiphunga kwiseli. Sihlola ukuqhubela phambili kwamva nje, iindlela zokuxilonga, kunye nokhetho lonyango olukhoyo, lubonelela ngolwazi oluxabisekileyo kwabo bafuna ukuqonda kunye nenkxaso ekuhambeni kolu hambo lunzima. Esi sixhobo sibandakanya iindlela ezahlukeneyo zonyango, iziphumo ebezingalindelekanga, kunye nokubaluleka kokhathalelo lobuqu olulungiselelwe iimfuno zesigulana kunye neemeko eTshayina.

Ukuqonda i-Squamous Non-Small Cell Lung Cancer (NSCLC)

Yintoni iSquamous Cell Carcinoma yeMiphunga?

I-squamous cell carcinoma luhlobo lwe umhlaza wemiphunga yeseli engeyincinci (NSCLC) eqala kwiiseli ze-squamous ezihlala kwi-bronchi (iindlela zomoya) zemiphunga. Ihlala inxulunyaniswa nembali yokutshaya, nangona abangatshayiyo nabo banokuchaphazeleka. Ukufunyaniswa kwangethuba kubalulekile ekuphuculeni iziphumo zonyango. Iimpawu zinokwahluka kodwa zinokubandakanya ukukhohlela okuzingileyo, ukukhohlela igazi (i-hemoptysis), iintlungu zesifuba, ukuphelelwa ngumphefumlo, kunye nokwehla kobunzima obungachazwanga.

Ukubekwa kunye nokuxilongwa kwe-Squamous NSCLC

Iqonga elichanekileyo libalulekile ekumiseleni okufanelekileyo China squamous non-incinci unyango umhlaza wemiphunga kwiseli isicwangciso. Oku kubandakanya indibaniselwano yobuchule bokucinga, obufana neX-reyi yesifuba, i-CT scans, i-PET scans, kunye ne-biopsy enokubakho ukuqinisekisa ukuxilongwa nokufumanisa ubungakanani bokusasazeka komhlaza. Ukufunyanwa kwangethuba kuphucula kakhulu i-prognosis kunye neendlela zonyango. Ubuchule bokucinga obuphezulu obukhoyo kwizibhedlele eziphambili kulo lonke elaseTshayina zibonelela ngolwazi oluchanekileyo lokuxilonga.

Iinketho zonyango lwe-Squamous NSCLC e-China

Ungenelelo ngotyando

Utyando luhlala luyinto ephambili yonyango lwendawo squamous non-mncinci umhlaza wemiphunga weseli, ejolise ekususeni ngokupheleleyo i-tumor kunye nezicubu ezijikelezileyo. Uhlobo lotyando luxhomekeke kubukhulu kunye nendawo yethumba. Ubuchwephesha obuncinci obuncinci njengotyando lwethoracoscopic oluncediswa yividiyo (VATS) luhlala lukhethwa ukunciphisa ixesha lokubuyisela. Amandla otyando akwinqanaba eliphezulu afumaneka lula kumaziko onyango amakhulu kulo lonke elaseTshayina.

Unyango ngamachiza

I-Chemotherapy isebenzisa amayeza okubulala iiseli zomhlaza, ezidla ngokusetyenziswa phambi kotyando (neoadjuvant) ukucutha amathumba okanye emva kotyando (adjuvant) ukunciphisa umngcipheko wokuphinda. Iirejimeni ezahlukeneyo zechemotherapy zikhona, ezilungiselelwe iimfuno zesigulana ngasinye kunye neempawu ezithile zethumba. Ukubonisana neengcali ze-oncologists kubalulekile ukuxoxa ngomngcipheko kunye noncedo lweenkqubo ezithile zechemotherapy.

Unyango ngemitha

Unyango ngemitha lusebenzisa imitha yemitha ephezulu ukutshabalalisa iiseli zomhlaza. Ingasetyenziswa yodwa okanye idityaniswe nolunye unyango. Unyango lwemitha yangaphandle lusetyenziswa ngokuqhelekileyo, ukuhambisa imitha kumatshini ongaphandle komzimba. Ukhetho ekujoliswe kulo lonyango lwemitha, njengonyango lwemitha yemitha ye-stereotactic (SBRT), zikwakhona ekujoliseni ngokuchanekileyo amathumba ngelixa unciphisa umonakalo kwizihlunu ezisempilweni ezingqongileyo.

Unyango ekujoliswe kulo

Unyango ekujoliswe kulo lusebenzisa amachiza ajolise ngokukodwa kwiimpawu ezizodwa zeeseli zomhlaza, ukunciphisa umonakalo kwiiseli eziphilileyo. Olu nyango luye lwatshintsha China squamous non-incinci unyango umhlaza wemiphunga kwiseli. Ukufumaneka kunye nokufaneleka kwezi zonyango ezijoliswe kuzo kuxhomekeke kwiinguqu ezithile zofuzo ezichongiweyo kwithumba.

Immunotherapy

I-Immunotherapy idibanisa amajoni omzimba ukulwa nomhlaza. I-immune checkpoint inhibitors ludidi lwamachiza omeleza isakhono somxokomezelo wokuzikhusela ekuboneni nasekutshabalaliseni iiseli zomhlaza. Olu nyango lubonakala lusebenza kakhulu kwiintlobo ezithile ze-NSCLC. Ulingo lwezonyango e-China luphonononga inkqubela phambili yamva nje kunyango lwe-immunotherapy yesquamous cell carcinoma.

Ukuhamba ngoNyango kunye neNkxaso eChina

Ukukhetha iZiko loNyango eliLungileyo

Ukukhetha iziko lomhlaza elibekekileyo kubalulekile kunyango oluyimpumelelo. Khangela izibhedlele ezineengcali ze-oncologists, itekhnoloji yonyango oluphezulu, kunye nerekhodi elomeleleyo lokunyanga i-NSCLC. Phanda ngokucokisekileyo, uthelekisa izakhono zezibhedlele ezahlukeneyo kunye nophononongo lwezigulane. Izibhedlele ezininzi eziphambili kwizixeko ezikhulu zaseTshayina zibonelela ngokhathalelo olubanzi lomhlaza wemiphunga.

Ukubaluleka kweziCwangciso zoNyango ezenzelwe wena

Indlela yobuqu yoku China squamous non-incinci unyango umhlaza wemiphunga kwiseli ithathela ingqalelo izinto ezinje ngobudala, impilo iyonke, kunye neempawu ezithile zofuzo zethumba. Le ndlela iqinisekisa isicwangciso sonyango esisebenzayo kunye nesincinci kwisigulane ngasinye. Ukusebenza ngokusondeleyo kunye neqela leengcali ezininzi ezihlukeneyo kubalulekile ekuphuhliseni isicwangciso esisebenzayo, sokhathalelo lomntu ngamnye.

Izibonelelo zeNkxaso kunye neeNethiwekhi

Ukumelana nomhlaza wemiphunga kufuna inkxaso yeemvakalelo nebonakalayo. Amaqela enkxaso, iinkonzo zokucebisa, kunye nemibutho yokuxhasa izigulane inokubonelela ngoncedo oluxabisekileyo. Ezi zixhobo zibonelela ngamathuba okunxibelelana nabanye abajongene nemingeni efanayo kunye nokwabelana ngamava, ukukhuthaza ukomelela kunye nethemba kulo lonke uhambo lonyango. Uthungelwano oluninzi lwenkxaso lukhona eTshayina, lubonelela ngoncedo kwizigulana kunye neentsapho zabo.

I-Disclaimer: Le ngcaciso yenzelwe iinjongo zemfundo kuphela kwaye akufanele ithathwe njengengcebiso yezonyango. Soloko udibana nengcali yokhathalelo lwempilo olufanelekileyo ukuze uxilongwe kunye nonyango lwaso nasiphi na isimo sonyango.

Ngolwazi oluthe vetshe kunye nokuphonononga iindlela zonyango, ungandwendwela IZiko loPhando ngoMhlaza laseShandong Baofa.

Imithombo: (Yongeza imithombo efanelekileyo apha, ucaphula idatha ethile esetyenzisiweyo, ukuqinisekisa ukuba onke amakhonkco angaphandle asebenzisa i-rel=nofollow)